Literature DB >> 19965841

The Audio Recorded Cognitive Screen (ARCS): a flexible hybrid cognitive test instrument.

Peter W Schofield1, Stephen J Lee, Terry J Lewin, Grant Lyall, Jonson Moyle, John Attia, Mark McEvoy.   

Abstract

OBJECTIVE: To describe and characterise the Audio Recorded Cognitive Screen (ARCS), a novel instrument that uses an audio device to administer selected neuropsychological tests to unsupervised individuals who write their responses in a special booklet for later scoring.
METHODS: The ARCS was administered to 733 individuals, comprising 550 from a normative community sample (mean age=59.14, range 18-84 years), 101 clinic patients and a separate validation sample of 82 community controls, who, together with the patients, underwent detailed neuropsychological assessments. These data were examined for the influence of demographic variables on ARCS performance, to establish normal performance and develop scoring routines, and to characterise the structure, reliability and validity of the instrument.
RESULTS: Age, gender and education influenced ARCS performance. ARCS tests were generally reliable and correlated well with corresponding conventional neuropsychological tests. Factor analyses indicated that the ARCS measures executive functioning/attention, memory, language, verbal fluency and visuospatial functioning. The ARCS discriminated well between normal (n=82), impaired (n=33) and demented (n=25) individuals, and significantly better than did the Mini Mental State Examination (MMSE), including on a single, demographically adjusted, global QuickARCS score obtainable in about 3 min of the clinician's time. Receiver Operating Characteristic analyses confirmed the superiority of the ARCS over MMSE as a screen for mild dementia (AUC 0.98, 99% CI 0.95 to 1.00) or cognitive impairment (AUC 0.90, 99% CI 0.83 to 0.97).
CONCLUSIONS: The ARCS has good validity and reliability, has a sound normative base and measures functioning in multiple cognitive domains while imposing minimal time demands upon the clinician.

Entities:  

Mesh:

Year:  2009        PMID: 19965841     DOI: 10.1136/jnnp.2009.188003

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.

Authors:  Sanela Slavković; Milica Lazić; Cynthia Honan; Čongor Nađ; Nina Brkić-Jovanović; Špela Golubović
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927

2.  Olfaction and Executive Cognitive Performance: A Systematic Review.

Authors:  Vasudeva Murthy Challakere Ramaswamy; Peter William Schofield
Journal:  Front Psychol       Date:  2022-05-09

Review 3.  The role of olfactory challenge tests in incipient dementia and clinical trial design.

Authors:  Peter W Schofield; Sally Finnie; Yun Ming Yong
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

4.  Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale.

Authors:  Margaret C Sewell; Xiaodong Luo; Judith Neugroschl; Mary Sano
Journal:  Int Psychogeriatr       Date:  2013-05-02       Impact factor: 3.878

5.  Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.

Authors:  Jameen Arm; Georg Oeltzschner; Oun Al-Iedani; Rod Lea; Jeannette Lechner-Scott; Saadallah Ramadan
Journal:  Eur J Radiol       Date:  2021-02-24       Impact factor: 3.528

6.  An olfactory 'stress test' may detect preclinical Alzheimer's disease.

Authors:  Peter W Schofield; Houman Ebrahimi; Alison L Jones; Grant A Bateman; Sonya R Murray
Journal:  BMC Neurol       Date:  2012-05-02       Impact factor: 2.474

7.  Thyroid antibodies, autoimmunity and cognitive decline: is there a population-based link?

Authors:  Kate Napthali; Michael Boyle; Huy Tran; Peter W Schofield; Roseanne Peel; Mark McEvoy; Christopher Oldmeadow; John Attia
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-05-21

8.  Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.

Authors:  Kira Groen; Vicki E Maltby; Rodney A Lea; Katherine A Sanders; J Lynn Fink; Rodney J Scott; Lotti Tajouri; Jeannette Lechner-Scott
Journal:  BMC Med Genomics       Date:  2018-05-21       Impact factor: 3.063

9.  Influence of Cognitive and Motor Abilities on the Level of Current Functioning in People with Multiple Sclerosis.

Authors:  Sanela Slavkovic; Spela Golubovic; Matilda Vojnovic; Congor Nadj
Journal:  Zdr Varst       Date:  2019-03-26

10.  Development of a self-administered web-based test for longitudinal cognitive assessment.

Authors:  Luis Ruano; Andreia Sousa; Milton Severo; Ivânia Alves; Márcio Colunas; Rui Barreto; Cátia Mateus; Sandra Moreira; Eduardo Conde; Virgílio Bento; Nuno Lunet; Joana Pais; Vítor Tedim Cruz
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.